National Health Investors, Inc. Forecasted to Post Q1 2021 Earnings of $1.35 Per Share (NYSE:NHI) – MarketBeat

0
49

National Health Investors, Inc. (NYSE:NHI) – KeyCorp issued their Q1 2021 EPS estimates for shares of National Health Investors in a report issued on Thursday, March 11th. KeyCorp analyst J. Sadler expects that the real estate investment trust will post earnings of $1.35 per share for the quarter. KeyCorp currently has a “Sector Weight” rating on the stock. KeyCorp also issued estimates for National Health Investors’ Q2 2021 earnings at $1.38 EPS, Q3 2021 earnings at $1.40 EPS, Q4 2021 earnings at $1.41 EPS, Q1 2022 earnings at $1.39 EPS, Q2 2022 earnings at $1.43 EPS, Q3 2022 earnings at $1.44 EPS and Q4 2022 earnings at $1.45 EPS. National Health Investors (NYSE:NHI) last released its earnings results on Sunday, February 21st. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.19). The firm had revenue of $81.24 million for the quarter, compared to analyst estimates of $84.22 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period last year, the business earned $1.41 earnings per share.

A number of other research analysts have also commented on the company. Berenberg Bank lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. Mizuho cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $56.00 to $55.00 in a research note on Wednesday, January 13th. BMO Capital Markets downgraded shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price objective for the company. in a report on Thursday, January 7th. Finally, Zacks Investment Research cut shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, February 24th. Three research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. National Health Investors presently has an average rating of “Hold” and a consensus price target of $61.57.

(Ad)

Warren Buffett recently dumped $800 million of Apple stock…

He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…

Shares of NYSE:NHI opened at $76.18 on Monday. The firm has a market capitalization of $3.44 billion, a PE ratio of 17.88 and a beta of 0.88. The company has a current ratio of 13.13, a quick ratio of 13.13 and a debt-to-equity ratio of 1.02. National Health Investors has a 1-year low of $31.37 and a 1-year high of $76.22. The business’s 50 day moving average is $68.71 and its 200-day moving average is $65.07.

A number of hedge funds have recently made changes to their positions in the stock. Marshall Wace North America L.P. bought a new stake in National Health Investors during the first quarter worth about $31,000. Amundi Pioneer Asset Management Inc. increased its holdings in National Health Investors by 2.5% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 79,619 shares of the real estate investment trust’s stock valued at $6,254,000 after purchasing an additional 1,960 shares in the last quarter. Mackay Shields LLC increased its holdings in National Health Investors by 7.4% during the 3rd quarter. Mackay Shields LLC now owns 40,600 shares of the real estate investment trust’s stock valued at $2,447,000 after purchasing an additional 2,800 shares in the last quarter. Raymond James & Associates raised its position in National Health Investors by 1.0% in the 3rd quarter. Raymond James & Associates now owns 81,975 shares of the real estate investment trust’s stock valued at $4,941,000 after purchasing an additional 843 shares during the last quarter. Finally, Jennison Associates LLC acquired a new position in National Health Investors in the third quarter worth $930,000. 65.72% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: Market Timing – The Benefits and the Danger

Earnings History and Estimates for National Health Investors (NYSE:NHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

7 Low-Priced Dividend Stocks Under $10

The recent trading activity surrounding low-priced stocks like GameStop (NYSE:GME) is a reminder to investors of the high-risk nature involved with these stocks. Often when a stock trades for under $10 (also termed a penny stock), it is trading that low for a reason. The company may not be profitable, or in the case of GameStop, it finds itself with a business model that no longer fits with consumer trends.

But that’s not always the case. It is possible to find low-priced stocks, even penny stocks, that offer great value. This is particularly true if the stock offers investors a dividend. Dividend-earning stocks are a diversification source for a consumer’s portfolio, particularly if the dividend gets reinvested. It’s literally like paying yourself for owning the stock.

And the stocks in this presentation look ready also to deliver some additional stock price growth that can increase your total return.

View the “7 Low-Priced Dividend Stocks Under $10”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here